Baird analyst Michael Ha upgraded CVS Health (CVS) to Outperform from Neutral with a price target of $82, up from $71.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- CVS vs. UNH: Which Healthcare Stock is a Better Buy After Q2 Earnings?
- Judges reject 2 cases challenging Medicare negotiation, The Hill reports
- CVS Health Earnings Call Highlights Growth Amid Challenges
- CVS Health price target raised to $99 from $95 at TD Cowen
- CVS Health’s Positive Trajectory: Strong Q2 Performance and Growth Prospects Drive Buy Rating